Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Oct. 6, 2022—Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.
VUMC lands grant to build top-line biosafety facility
Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
Masking guidance updated — Masks no longer required in non-clinical areas
Sep. 23, 2022—Leaders across VUMC continue to monitor important metrics around COVID-19, including rates of transmission and severe infection, which have been steadily dropping. Most of the local counties served by VUMC are no longer in the “high” category for severe infections, as determined by the Centers for Disease Control and Prevention. Additionally, new bivalent COVID-19 booster...
PheWAS reveals post-COVID-19 diagnoses
Sep. 8, 2022—Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.
Neurologic complications common in children hospitalized with COVID
Aug. 25, 2022—Vanderbilt researchers have found another reason to vaccinate children against COVID-19: to help reduce the likelihood of neurologic complications caused by the virus.
COVID antibody research conducted at VUMC lands national award
Aug. 24, 2022—A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.
Reminder: COVID-19 infection prevention guidelines for all VUMC workforce members
Aug. 24, 2022—VUMC leaders continue to track key metrics such as transmission rates for COVID-19 in the community and county statistics for those who are vaccinated while keeping abreast of evolving practices for infection prevention and changing federal and state requirements for compliance with workplace safety standards. VUMC is following CDC guidance for health care facilities, not...
NAM special publication focuses on COVID lessons learned
Aug. 10, 2022—A new special publication from the National Academy of Medicine spotlights the opportunity to leverage lessons learned from the pandemic to transform health, health care and health delivery in the United States.
Video vital for telehealth visits
Jul. 28, 2022—Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
Jul. 20, 2022—In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Convalescent plasma doesn’t help severely ill COVID patients: study
Jul. 7, 2022—A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover
Study shows two vaccine doses for mothers eases COVID complications for infants
Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.